Oct 20, 2024 · At this year's American Academy of Ophthalmology (AAO) meeting, Jonathan Brugger, MD, spoke about the changing approach to epimacular membranes and the use of brilliant blue in the procedure.

Jan 3, 2025 · The Data and Safety Monitoring Board (DSMB) for the OCU410 ArMaDa clinical trial convened and approved continuation of the second phase of the Phase 1/2 study. The candidate being evaluated, OCU410 (AAV5-hRORA), is a novel modifier gene therapy candidate being developed for geographic atrophy (GA ...

Apr 2, 2024 · Age-related macular degeneration (AMD) is among the leading causes of vision loss. For this reason, many companies see the importance of developing treatment options that would allow patients to preserve or potentially regain some visual acuity.

Oct 18, 2024 · Thomas Aaberg, Jr, MD, Neurotech's Chief Medical Officer, shared some insights on the company's recent presentation as well as their upcoming presentations at the annual American Academy of Ophthalmology meeting being held in Chicago, Illinois.

Oct 25, 2024 · The results of a new retrospective cohort study suggest that use of curcuma-based nutritional supplements (CBNS) may be associated with the reduced risk of developing age-related macular degeneration (AMD) or progression to the later disease stages, 1 according to the first author Amer F. Alsoudi, MD, from the Department of Ophthalmology, Baylor College of Medicine, Houston.

Nov 19, 2024 · Astellas Pharma Inc. announced the United States Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for avacincaptad pegol intravitreal solution (IZERVAY).

Nov 13, 2024 · PulseSight Therapeutics SAS presented new data on its lead program PST-611, a DNA plasmid expressing human transferrin, in dry age-related macular degeneration (AMD) and geographic atrophy (GA) at the European Association …

Dec 11, 2024 · Exegenesis Bio provided an update on the company’s treatment candidates for wet age-related macular degeneration (wet AMD). EXG102 is an investigational gene therapy for wet AMD that is administered by subretinal injection.

Dec 20, 2024 · Curacle presented the results of its phase 2a clinical trial of CU06 for diabetic macular edema (DME) at the 4th Asia Retina Congress. This meeting is being held alongside the 2024 Annual Meeting of the Korean Retina Society in Seoul.

Oct 31, 2024 · Valerie Biousse, MD, from the Emory University in Atlanta, Georgia, shared insights on how ocular imaging in the emergency department can provide timely, accurate diagnosis while also benefiting the on-call ophthalmologists.